» Articles » PMID: 33717939

Indeterminate Pulmonary Nodules Are Not Associated with Worse Overall Survival in Ewing Sarcoma

Overview
Specialty Orthopedics
Date 2021 Mar 15
PMID 33717939
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Lung metastases are a negative prognostic factor in Ewing sarcoma, however, the incidence and significance of sub-centimetre pulmonary nodules at diagnosis is unclear. The aims of this study were to (1): determine the incidence of indeterminate pulmonary nodules (IPNs) in patients diagnosed with Ewing sarcoma (2); establish the impact of IPNs on overall and metastasis-free survival and (3) identify patient, oncological and radiological factors that correlate with poorer prognosis in patients that present with IPNs on their staging chest CT.

Materials & Methods: Between 2008 and 2016, 173 patients with a first presentation of Ewing sarcoma of bone were retrospectively identified from an institutional database. Staging and follow-up chest CTs for all patients with IPN were reviewed by a senior radiologist. Clinical and radiologic course were examined to determine overall- and metastasis-free survival for IPN patients and to identify demographic, oncological or nodule-specific features that predict which IPN represent true lung metastases.

Results: Following radiologic re-review, IPN were found in 8.7% of patients. Overall survival for IPN patients was comparable to those with a normal staging chest CT (2-year overall survival of 73.3% [95% CI 43.6-89] and 89.4% [95% CI 81.6-94], respectively; p = 0.34) and was significantly better than for patients with clear metastases (46.0% [95% CI 31.9-59]; p < 0.0001). Similarly, there was no difference in metastasis-free survival between 'No Metastases' and 'IPN' patients (p = 0.16). Lung metastases developed in 40% of IPN patients at a median 9.6 months. Reduction of nodule size on neoadjuvant chemotherapy was associated with worse overall survival in IPN patients (p = 0.0084).

Conclusion: IPN are not uncommon in patients diagnosed with Ewing sarcoma. In this study, we were unable to detect a difference in overall- or metastasis-free survival between patients with IPN at diagnosis and patients with normal staging chest CTs.

Citing Articles

UK guidelines for the management of bone sarcomas.

Gerrand C, Amary F, Anwar H, Brennan B, Dileo P, Kalkat M Br J Cancer. 2024; 132(1):32-48.

PMID: 39550489 PMC: 11723950. DOI: 10.1038/s41416-024-02868-4.


The clinical significance of indeterminate pulmonary nodules in patients with primary bone sarcoma: a systematic review.

Hassan M, Ariyaratne S, Azzopardi C, Iyengar K, Davies A, Botchu R Br J Radiol. 2024; 97(1156):747-756.

PMID: 38346703 PMC: 11027319. DOI: 10.1093/bjr/tqae040.


Ewing sarcoma of the temporal bone with aneurysmal bone cyst-like changes: A rare case report with an unusual radiological presentation.

Lloret I, Hompland I, Lobmaier I, Sundseth J, Server A Neuroradiol J. 2023; 37(5):640-644.

PMID: 37923348 PMC: 11456207. DOI: 10.1177/19714009231212358.


What Is the Significance of Indeterminate Pulmonary Nodules in High-Grade Soft Tissue Sarcomas? A Retrospective Cohort Study.

Brookes M, Chan C, Crowley T, Ragbir M, Beckingsale T, Ghosh K Cancers (Basel). 2023; 15(13).

PMID: 37444641 PMC: 10340540. DOI: 10.3390/cancers15133531.


Prognostic Impact of Pulmonary Metastasectomy in Bone Sarcoma Patients: A Retrospective, Single-Centre Study.

Smolle M, Kogler A, Andreou D, Scheipl S, Bergovec M, Castellani C Cancers (Basel). 2023; 15(6).

PMID: 36980620 PMC: 10046382. DOI: 10.3390/cancers15061733.

References
1.
Bacci G, Ferrari S, Longhi A, Versari M, Forni C, Donati D . Local and systemic control in Ewing's sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery. J Bone Joint Surg Br. 2003; 85(1):107-14. DOI: 10.1302/0301-620x.85b1.12781. View

2.
Albergo J, Gaston C, Laitinen M, Darbyshire A, Jeys L, Sumathi V . Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response. Bone Joint J. 2016; 98-B(8):1138-44. DOI: 10.1302/0301-620X.98B8.37346. View

3.
Bosma S, Ayu O, Fiocco M, Gelderblom H, Dijkstra P . Prognostic factors for survival in Ewing sarcoma: A systematic review. Surg Oncol. 2018; 27(4):603-610. DOI: 10.1016/j.suronc.2018.07.016. View

4.
McWilliams A, Tammemagi M, Mayo J, Roberts H, Liu G, Soghrati K . Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med. 2013; 369(10):910-9. PMC: 3951177. DOI: 10.1056/NEJMoa1214726. View

5.
Dudeck O, Zeile M, Andreou D, Schnapauff D, Pech M, Wieners G . Computed tomographic criteria for the discrimination of subcentimeter lung nodules in patients with soft-tissue sarcomas. Clin Imaging. 2011; 35(3):174-9. DOI: 10.1016/j.clinimag.2010.06.005. View